MedTrace Logo

Developing A Gout Action Plan in Primary Care Setting in Singapore

NCT07061587 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-07-11

No results posted yet for this study

Summary

The goal of this clinical trial is to develop a gout action plan in primary care setting in Singapore among adult patients with gout, and to learn if the gout action plan can improve gout control.

The main questions it aims to answer are:

* How do we develop a gout action plan in primary care setting in Singapore?
* What is the feasibility and estimate effectiveness of the developed gout action plan?
* Does gout action plan reduce frequency of gout flares in patients with gout?

Researchers will compare gout action plan to usual clinical care to see whether gout action plan helps in improving gout control.

Participants in intervention arm will be:

* given gout action plan and follow up for a course of 6 months
* asked to keep track of their gout symptoms
* follow up on the number of gout flares they have.

Conditions

  • Gout; Hyperuricemia
  • Gout Flare
  • Gout Chronic

Interventions

BEHAVIORAL

Gout action plan

Gout action plan (that we aim to develop and refine during the study based on traffic light color system which will be categorized into zone system- green zone (well controlled), yellow zone (mild symptoms), red zone (severe symptoms). It will outline how to manage gout, identifying triggers, recognizing symptoms, appropriate medication usage, and when to seek medical attention)

Sponsors & Collaborators

  • SingHealth Polyclinics

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2026-05-31
Completion
2027-07-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07061587 on ClinicalTrials.gov